Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (3)
P 1 (7)
P 2 (1)

Trial Status

Recruiting7
Not Yet Recruiting5
Completed1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07850869RecruitingPrimary

A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced Metastatic Breast Cancer

NCT07374796Not Yet RecruitingPrimary

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

NCT07803549Not ApplicableCompletedPrimary

The Effect of Self-Management Interventions Among Patients With Breast Cancer Related-Lymphedema

NCT07738341Phase 1Not Yet RecruitingPrimary

GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)

NCT07457541Phase 1Active Not Recruiting

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

NCT07658183Phase 2Not Yet RecruitingPrimary

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

NCT07612891Phase 1RecruitingPrimary

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor

NCT07553572Not ApplicableRecruitingPrimary

Remote Monitoring and Symptom Management Digital Application

NCT07523516Not Yet RecruitingPrimary

Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer

NCT07486089Phase 1RecruitingPrimary

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

NCT07478900Not ApplicableRecruitingPrimary

Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer

NCT07410676Phase 1Recruiting

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT07390838Phase 1Recruiting

A Study of SH009 Injection in Patients With Advanced Solid Tumors.

NCT07260058Phase 1Not Yet Recruiting

Immune Cell Therapy for Advanced Solid Tumors

Showing all 14 trials

Research Network

Activity Timeline